Anti-toxoplasmosis effects of oleuropein isolated from Fraxinus rhychophylla

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 12, 2008, Pages 2273-2276

  Jiang, Jing Hua ^a   Jin, Chun Mei ^a   Kim, Youn Chul ^a   Kim, Hun Soo ^a   Park, Won Cheol ^b   Park, Hyun ^a  

^a Wonkwang University School of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Fraxinus rhynchophylla; Oleuropein; Toxoplasma gondii; Toxoplasmosis

Indexed keywords

OLEUROPEIN; PYRIMETHAMINE; SULFADIAZINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; DRUG SELECTIVITY; FRAXINUS; IN VITRO STUDY; IN VIVO STUDY; LIVER CYST; LIVER GRANULOMA; LIVER NECROSIS; MALE; MOUSE; NONHUMAN; SPLEEN CYST; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTI-INFECTIVE AGENTS; CELL LINE; CELL PROLIFERATION; COLORING AGENTS; DOGS; FEMALE; FRAXINUS; LIVER; MICE; MICROBIAL SENSITIVITY TESTS; PERITONEAL CAVITY; PYRANS; SPLEEN; TOXOPLASMA; TOXOPLASMOSIS;

EID: 57349161464     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.2273     Document Type: Article

References (16)

1. Dukes C., Luft B., Durack D., "Toxoplasmosis, in Infections of the Central Nervous System," ed. by Scheld W. M., Whitley R. J., Durack D. T., Lippincott-Raven, Philadelphia, 1997, pp. 785-806.
2. Remington J. S., McLeod R., Thulliez P., Desmonts G., "Toxoplasmosis in Infectious Diseases of the Fetus and Newborn Infant," 5th ed., ed. by Remington J. S., Klein J. O., WB Saunders, Philadelphia, 2001, pp. 205-346.
3. Alan S. B., Catherine A. S., Charles P. Q., Liyan L., Vicki P. B., Ezra S. S., Am. J. Psychiatry, 162, 767-773 (2005).
4. Dubey J. P., Beattie C. P., "Toxoplasmosis of Animals and Man," CRC Press, Boca Raton, Florida, 1988.
5. Arendt G., Von Giesen H. J., Hefter H., Neuen-Jacob E., Roick H., Jablonowski H., Acta Neurol. Scand., 100, 178-184 (1999).
6. McFadden D. C., Seeber F., Boothroyd J. C., Antimicrob. Agents Chemother., 41, 1849-1853 (1997).
7. Georgiev V. S., Drugs, 48, 179-188 (1994).
8. Kim N. Y., Pae H. O., Ko Y. S., Yoo J. C., Choi B. M., Jun C. D., Chung H. T., Inagaki M., Higuchi R., Kim Y. C., Planta Med., 65, 656-658 (1999).
9. Andreadou I., Iliodromitis E. K., Mikros E., Constantinou M., Agalias A., Magiatis P., Skaltsounis A. L., Kamber E., Tsantili-Kakoulidou A., Kremastinos D. T., J. Nutr., 136, 2213-2219 (2006).
10. Cory A. H., Owen J. C., Barltrop J. A., Cory J. G., Cancer Commun., 3, 207-212 (1991).
11. Riss T. L., Moravec R. A., Mol. Biol. Cell, 3, 184a (1992).
12. Berridge M. V., Tan A. S., Arch. Biochem. Biophys., 303, 474-482 (1993).
13. Murakami N., Sugimoto M., Kawanishi M., Tamura S., Kim H. S., Begum K., Wataya Y., Kobayashi M., J. Med. Chem., 46, 638-641 (2003).
14. Puel C., Mathey J., Agalias A., Kati-Coulibaly S., Mardon J., Obled C., Davicco M. J., Lebecque P., Horcajada M. N., Skaltsounis A. L., Coxam V., Clin. Nutr., 25, 859-868 (2006).
15. Choi J. S., Chung P. R., Soh C. T., Yonsei J. Med. Sci., 18, 340-354 (1985).
16. Hamdi H. K., Castellon R., Biochem. Biophys. Res. Commun., 334, 769-778 (2005).